arrow
J

Jingjing Feng

University System of Maryland
H指数:21
被引数:1,545

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bisecting GlcNAc expression by bone marrow stromal cells modulates TGF-f31-driven macrophage polarization in myeloid leukemias

Feng, J.; Gou, J.; Wang, Y.; Wei, W.; Ma, Y.; Ren, X.; Zhao, C.; Cheng, X.; Lei, L.; Tan, Z.; et al. 骨髓基质细胞介导的乙酰葡萄糖胺表达可调节髓系白血病中TGF-β1驱动的巨噬细胞极化。Haematologica 2025, 110, 3009–3021. [Google Scholar] [CrossRef]

2025-12-011
OA
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

CD19靶向和BCMA靶向CAR-T细胞的联合输注治疗难治性系统性红斑狼疮:一项1期临床试验

2025-09-240
PRE
Safety and efficacy of autologous humanized CD19 CAR-T cell therapy for relapsed/refractory B-cell non-Hodgkin lymphoma

自体人源化CD19 CAR-T细胞疗法治疗复发/难治性B细胞非霍奇金淋巴瘤的安全性与有效性

2025-08-200
OAAI
Dasatinib and CAR T-Cell Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Nonrandomized Clinical Trial

达沙替尼和CAR T细胞疗法在初诊费城染色体阳性急性淋巴细胞白血病中的应用:一项非随机临床试验

2025-04-170
PRE
Novel Meningoencephalomyelitis Associated With Vimentin IgG Autoantibodies

新型与Vimentin IgG自身抗体相关的脑膜炎脑脊髓炎

2025-01-211
PRE
Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia

序贯CD19和CD22 CAR-T疗法在复发/难治性成人B细胞急性淋巴细胞白血病中表现出显著的疗效和良好的安全性。

2025-01-030
OA
HLA Fully-Mismatched Sibling-Derived CD7 CAR-T Therapy Bridging to Haploidentical Hematopoietic Stem Cell Transplantation for Hepatosplenic ?d T-cell Lymphoma

HLA完全不匹配的同胞来源的CD7 car-t疗法过渡到单倍体造血干细胞移植治疗肝脾?d T细胞淋巴瘤

2023-09-042
OAAI